Diseases, Conditions, Syndromes

Plague kills 19 in Madagascar

An outbreak of plague in Madagascar has killed 19 people and may have infected 85 others in just two months, the Indian Ocean island nation's health minister said Thursday.

Diseases, Conditions, Syndromes

Five die as plague resurfaces in Madagascar

Pneumonic plague has killed five people in Madagascar since August, a top health official told AFP on Thursday, but stressed the situation was under control.

Oncology & Cancer

Scientists identify gene mutations in smoking-related cancers

African-Americans typically have worse outcomes from smoking-related cancers than Caucasians, but the reasons for this remain elusive. However, scientists at Wake Forest Baptist Medical Center have taken a big step toward ...

Diseases, Conditions, Syndromes

Ebola linked to habitat destruction

A Massey University veterinary scientist has co-authored research suggesting that Ebola virus emergence is linked to the clearing of animal habitat through deforestation in West and Central Africa.

Medications

Judge halts Alzheimer's drug swap until July

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

Other

Venezuelan expert on leprosy dead at 100

Venezuelan scientist and doctor Jacinto Convit, renowned for developing a vaccine against leprosy, died on Monday in Caracas at the age of 100, his family said.

Medications

Actavis to buy Forest Labs in $25 billion deal (Update 3)

Irish drugmaker Actavis PLC plans to buy Forest Laboratories Inc. for about $25 billion, catapulting little-known Actavis into the world's No. 15 drug company, with an unusual one-stop-shopping model giving it an edge: more ...

Other

Forest Labs plans to cut $500M in spending

Forest Laboratories says it plans to cut $500 million in costs in about two years, and also plans to buy back up to $1 billion in company stock.

page 5 from 7